Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dustin Waters

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Pediatric Pulmonology|September 6, 2012
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodiumDavid C Young, Jeffery T Zobell, C Dustin Waters, et al.
Pediatric Pulmonology|January 30, 2013
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summaryJeffery T Zobell, David C Young, C Dustin Waters, et al.
Pediatric Pulmonology|September 4, 2013
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. AminoglycosidesDavid C Young, Jeffery T Zobell, Chris Stockmann, et al.
Pediatric Pulmonology|September 6, 2012
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolonesChris Stockmann, Catherine M T Sherwin, Jeffery T Zobell, et al.
Pediatric Pulmonology|April 27, 2011
A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patientsJeffery T Zobell, David C Young, C Dustin Waters, et al.
The American Journal of Emergency Medicine|December 16, 2020
Antibiotic prescribing for adult bacteriuria and pyuria in community hospital emergency departmentsJohn J Veillette, C Dustin Waters, Stephanie S Gelman, et al.
Open Forum Infectious Diseases|April 26, 2024
Real-World Effectiveness of Intravenous and Oral Antibiotic Stepdown Strategies for Gram-Negative Complicated Urinary Tract Infection With BacteremiaJohn J Veillette, Stephanie S May, Sameer Alzaidi, et al.
Open Forum Infectious Diseases|February 19, 2024
Oral β-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated <i>Escherichia coli</i> or <i>Klebsiella</i> Species Bacteremia From a Urinary Tract SourceSameer Alzaidi, John J Veillette, Stephanie S May, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|July 28, 2023
Outcomes of patients with bacteriuria/pyuria of clinically undetermined significance (BPCUS) treated with antibiotics in 23 community hospital emergency departmentsJohn J Veillette, C Dustin Waters, Jared Olson, et al.
Journal of Hospital Medicine|May 2, 2023
Effect of tele-COVID rounds and a tele-stewardship intervention on antibiotic use in COVID-19 patients admitted to 17 small community hospitalsStephanie Shealy May, John J Veillette, Brandon J Webb, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Pediatric Pulmonology|September 6, 2012
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodiumDavid C Young, Jeffery T Zobell, C Dustin Waters, et al.
Pediatric Pulmonology|January 30, 2013
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summaryJeffery T Zobell, David C Young, C Dustin Waters, et al.
Pediatric Pulmonology|September 4, 2013
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. AminoglycosidesDavid C Young, Jeffery T Zobell, Chris Stockmann, et al.
Pediatric Pulmonology|September 6, 2012
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolonesChris Stockmann, Catherine M T Sherwin, Jeffery T Zobell, et al.
Pediatric Pulmonology|April 27, 2011
A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patientsJeffery T Zobell, David C Young, C Dustin Waters, et al.
The American Journal of Emergency Medicine|December 16, 2020
Antibiotic prescribing for adult bacteriuria and pyuria in community hospital emergency departmentsJohn J Veillette, C Dustin Waters, Stephanie S Gelman, et al.
Open Forum Infectious Diseases|April 26, 2024
Real-World Effectiveness of Intravenous and Oral Antibiotic Stepdown Strategies for Gram-Negative Complicated Urinary Tract Infection With BacteremiaJohn J Veillette, Stephanie S May, Sameer Alzaidi, et al.
Open Forum Infectious Diseases|February 19, 2024
Oral β-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated <i>Escherichia coli</i> or <i>Klebsiella</i> Species Bacteremia From a Urinary Tract SourceSameer Alzaidi, John J Veillette, Stephanie S May, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|July 28, 2023
Outcomes of patients with bacteriuria/pyuria of clinically undetermined significance (BPCUS) treated with antibiotics in 23 community hospital emergency departmentsJohn J Veillette, C Dustin Waters, Jared Olson, et al.
Journal of Hospital Medicine|May 2, 2023
Effect of tele-COVID rounds and a tele-stewardship intervention on antibiotic use in COVID-19 patients admitted to 17 small community hospitalsStephanie Shealy May, John J Veillette, Brandon J Webb, et al.
Pageof 3